Safety, Tolerability, Biological Effects and Pharmacokinetics of BIIL 284 BS in Healthy Males

NCT02265302 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIIL 284 oral solution
DRUG: BIIL 284 wetability improved formulation (WIF) tablets
DRUG: Placebo

Sponsor

Boehringer Ingelheim